These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


188 related items for PubMed ID: 9415011

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Flow-mediated vasodilation of human epicardial coronary arteries: effect of inhibition of nitric oxide synthesis.
    Shiode N, Morishima N, Nakayama K, Yamagata T, Matsuura H, Kajiyama G.
    J Am Coll Cardiol; 1996 Feb; 27(2):304-10. PubMed ID: 8557898
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Nitric oxide production by coronary conductance and resistance vessels in hypercholesterolemia patients.
    Shiode N, Nakayama K, Morishima N, Yamagata T, Matsuura H, Kajiyama G.
    Am Heart J; 1996 Jun; 131(6):1051-7. PubMed ID: 8644581
    [Abstract] [Full Text] [Related]

  • 7. Role of endothelium-derived nitric oxide in coronary vasodilatation induced by pacing tachycardia in humans.
    Egashira K, Katsuda Y, Mohri M, Kuga T, Tagawa T, Kubota T, Hirakawa Y, Takeshita A.
    Circ Res; 1996 Aug; 79(2):331-5. PubMed ID: 8756012
    [Abstract] [Full Text] [Related]

  • 8. The role of nitric oxide in bradykinin-induced dilation of coronary resistance vessels in patients with hypercholesterolemia.
    Kato M, Shiode N, Teragawa H, Hirao H, Yamada T, Yamagata T, Matsuura H, Kajiyama G.
    Intern Med; 1999 May; 38(5):394-400. PubMed ID: 10397075
    [Abstract] [Full Text] [Related]

  • 9. Nitric oxide activity in the atherosclerotic human coronary circulation.
    Quyyumi AA, Dakak N, Mulcahy D, Andrews NP, Husain S, Panza JA, Cannon RO.
    J Am Coll Cardiol; 1997 Feb; 29(2):308-17. PubMed ID: 9014982
    [Abstract] [Full Text] [Related]

  • 10. Coronary vasodilation induced by angiotensin-converting enzyme inhibition in vivo: differential contribution of nitric oxide and bradykinin in conductance and resistance arteries.
    Sudhir K, Chou TM, Hutchison SJ, Chatterjee K.
    Circulation; 1996 May 01; 93(9):1734-9. PubMed ID: 8653880
    [Abstract] [Full Text] [Related]

  • 11. Adrenomedullin causes coronary vasodilation in humans: effects of inhibition of nitric oxide synthesis.
    Ueda K, Teragawa H, Kimura M, Matsuda K, Higashi Y, Yamagata T, Oshima T, Yoshizumi M, Chayama K.
    J Cardiovasc Pharmacol; 2005 Oct 01; 46(4):534-9. PubMed ID: 16160609
    [Abstract] [Full Text] [Related]

  • 12. Importance of nitric oxide in the coronary artery at rest and during pacing in humans.
    Nishikawa Y, Ogawa S.
    J Am Coll Cardiol; 1997 Jan 01; 29(1):85-92. PubMed ID: 8996299
    [Abstract] [Full Text] [Related]

  • 13. Leptin causes nitric-oxide independent coronary artery vasodilation in humans.
    Matsuda K, Teragawa H, Fukuda Y, Nakagawa K, Higashi Y, Chayama K.
    Hypertens Res; 2003 Feb 01; 26(2):147-52. PubMed ID: 12627874
    [Abstract] [Full Text] [Related]

  • 14. Bradykinin-induced vasodilation of human coronary arteries in vivo: role of nitric oxide and angiotensin-converting enzyme.
    Kuga T, Mohri M, Egashira K, Hirakawa Y, Tagawa T, Shimokawa H, Takeshita A.
    J Am Coll Cardiol; 1997 Jul 01; 30(1):108-12. PubMed ID: 9207629
    [Abstract] [Full Text] [Related]

  • 15. Role of nitric oxide in substance P-induced vasodilation differs between the coronary and forearm circulation in humans.
    Tagawa T, Mohri M, Tagawa H, Egashira K, Shimokawa H, Kuga T, Hirooka Y, Takeshita A.
    J Cardiovasc Pharmacol; 1997 Apr 01; 29(4):546-53. PubMed ID: 9156366
    [Abstract] [Full Text] [Related]

  • 16. Endogenous nitric oxide contributes to bradykinin-stimulated glucose uptake but attenuates vascular tissue-type plasminogen activator release.
    Pretorius M, Brown NJ.
    J Pharmacol Exp Ther; 2010 Jan 01; 332(1):291-7. PubMed ID: 19841473
    [Abstract] [Full Text] [Related]

  • 17. Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolaemia.
    Fukuda Y, Teragawa H, Matsuda K, Yamagata T, Matsuura H, Chayama K.
    Heart; 2002 Mar 01; 87(3):264-9. PubMed ID: 11847169
    [Abstract] [Full Text] [Related]

  • 18. Hypomagnesemia inhibits nitric oxide release from coronary endothelium: protective role of magnesium infusion after cardiac operations.
    Pearson PJ, Evora PR, Seccombe JF, Schaff HV.
    Ann Thorac Surg; 1998 Apr 01; 65(4):967-72. PubMed ID: 9564911
    [Abstract] [Full Text] [Related]

  • 19. Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis.
    Quyyumi AA, Dakak N, Andrews NP, Husain S, Arora S, Gilligan DM, Panza JA, Cannon RO.
    J Clin Invest; 1995 Apr 01; 95(4):1747-55. PubMed ID: 7706483
    [Abstract] [Full Text] [Related]

  • 20. Characterization of an inhibitor of nitric oxide synthase in human-hand veins.
    Bedarida GV, Kim D, Blaschke TF, Hoffman BB.
    Horm Metab Res; 1994 Feb 01; 26(2):109-12. PubMed ID: 7515369
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.